These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2352582)

  • 1. Angiotensin-converting enzyme inhibitors in diabetics with hypertension--a cautionary note.
    Mohamed AS; Yaqoob M; Bell GM
    Nephron; 1990; 55(1):83-4. PubMed ID: 2352582
    [No Abstract]   [Full Text] [Related]  

  • 2. Hypoglycemia associated with the administration of angiotensin-converting enzyme inhibitor in a patient with diabetes mellitus.
    Sakaguchi H; Maeda S; Fukunaga Y; Inoue D; Koshiyama H
    Intern Med; 1997 Jan; 36(1):77. PubMed ID: 9058108
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic controversies in hypertension management: angiotensin converting enzyme (ACE) inhibitors or angiotensin receptor blockers for diabetic nephropathy? A case for ACE inhibitors.
    Crook ED; Preddie DC
    Ethn Dis; 2002; 12(4):S3-49-52. PubMed ID: 12477155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibition and renovascular disease.
    Carr S
    Diabet Med; 2001 Jan; 18 Suppl 1():4-6. PubMed ID: 11289190
    [No Abstract]   [Full Text] [Related]  

  • 5. [Antihypertensive treatment in the type 2 diabetic].
    Fournier A
    Nephrologie; 2000; 21(4):203-4. PubMed ID: 10976435
    [No Abstract]   [Full Text] [Related]  

  • 6. Introduction.
    Dahlöf B; Ritz E
    Acta Diabetol; 2005 Apr; 42 Suppl 1():S1-2. PubMed ID: 15868114
    [No Abstract]   [Full Text] [Related]  

  • 7. Polycystic kidney disease and angiotensin-converting enzyme inhibitors.
    Bursztyn M
    Ann Intern Med; 1992 Jul; 117(1):90. PubMed ID: 1596054
    [No Abstract]   [Full Text] [Related]  

  • 8. The diabetic with renal impairment.
    Tallis GA; Phillips PJ; Popplewell PY
    Aust Fam Physician; 1997 Sep; 26(9):1091-2. PubMed ID: 9382724
    [No Abstract]   [Full Text] [Related]  

  • 9. Severe reduction of renal function in hypertensives and/or diabetics induced by angiotensin-converting enzyme inhibitors.
    Gotloib L; Jaichenko S; Fudin R; Shostok A
    Nephron; 1995; 71(2):230-1. PubMed ID: 8569962
    [No Abstract]   [Full Text] [Related]  

  • 10. [Angiotensin-converting enzyme inhibitors. Principles and rules of use].
    Eicher JC; Wolf JE
    Rev Prat; 1998 Apr; 48(7):771-6. PubMed ID: 11767373
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypertension and diabetic nephropathy, a dangerous duo].
    Hausberg M; Hohage H; Kosch M
    Med Klin (Munich); 2005 Nov; 100(11):729-37; quiz 738-9. PubMed ID: 16328181
    [No Abstract]   [Full Text] [Related]  

  • 12. Systolic hypertension; diabetes mellitus; renal dysfunction; and the use of ACE inhibitors in African-American population.
    Wurtzbacher JD; Gourley GA; Cushman WC; Fine D; Miller J; Shane R; Schultz K
    Am J Manag Care; 2000 Feb; 6(3 Suppl):S141-3. PubMed ID: 10977445
    [No Abstract]   [Full Text] [Related]  

  • 13. [Angiotensin converting enzyme inhibitors in the treatment of diabetes].
    Smahelová A
    Vnitr Lek; 2003 Dec; 49(12):948-51. PubMed ID: 15040161
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertension arm of ADVANCE defines extent of renal protection using perindopril/indapamide in type 2 diabetics.
    Cardiovasc J Afr; 2008; 19(4):226. PubMed ID: 18776973
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible impairment of renal function associated with enalapril in a diabetic patient.
    Albareda MM; Corcoy R
    CMAJ; 1998 Nov; 159(10):1279-81. PubMed ID: 9861226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renoprotection with antihypertensive agents.
    Hilgers KF; Mann JF
    Lancet; 2002 May; 359(9318):1693; author reply 1693-4. PubMed ID: 12020551
    [No Abstract]   [Full Text] [Related]  

  • 17. The end of the road for dual renin-angiotensin system blockade in diabetic nephropathy: which way now?
    Advani A
    Can J Diabetes; 2014 Oct; 38(5):292-5. PubMed ID: 25172268
    [No Abstract]   [Full Text] [Related]  

  • 18. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 19. [Acute kidney failure during converting enzyme inhibitor therapy. A too frequent diagnosis].
    Winckel A; Rezaiguia S; Melin JP; Chanard J
    Presse Med; 1991 Feb; 20(6):265-6. PubMed ID: 1826166
    [No Abstract]   [Full Text] [Related]  

  • 20. Questionnaire study and audit of use of angiotensin converting enzyme inhibitor and monitoring in general practice: the need for guidelines to prevent renal failure.
    Kalra PA; Kumwenda M; MacDowall P; Roland MO
    BMJ; 1999 Jan; 318(7178):234-7. PubMed ID: 9915733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.